These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

444 related items for PubMed ID: 16125378

  • 1. Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX.
    Chiang N, Arita M, Serhan CN.
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):163-77. PubMed ID: 16125378
    [Abstract] [Full Text] [Related]

  • 2. Novel endogenous small molecules as the checkpoint controllers in inflammation and resolution: entrée for resoleomics.
    Serhan CN, Chiang N.
    Rheum Dis Clin North Am; 2004 Feb; 30(1):69-95. PubMed ID: 15061569
    [Abstract] [Full Text] [Related]

  • 3. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution.
    Serhan CN.
    Prostaglandins Leukot Essent Fatty Acids; 2005 Feb; 73(3-4):141-62. PubMed ID: 16005201
    [Abstract] [Full Text] [Related]

  • 4. The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo.
    Chiang N, Serhan CN, Dahlén SE, Drazen JM, Hay DW, Rovati GE, Shimizu T, Yokomizo T, Brink C.
    Pharmacol Rev; 2006 Sep; 58(3):463-87. PubMed ID: 16968948
    [Abstract] [Full Text] [Related]

  • 5. Lipoxins and aspirin-triggered lipoxins in neutrophil adhesion and signal transduction.
    Filep JG, Khreiss T, József L.
    Prostaglandins Leukot Essent Fatty Acids; 2005 Sep; 73(3-4):257-62. PubMed ID: 15979865
    [Abstract] [Full Text] [Related]

  • 6. Lipid-derived mediators in endogenous anti-inflammation and resolution: lipoxins and aspirin-triggered 15-epi-lipoxins.
    Serhan CN, Chiang N.
    ScientificWorldJournal; 2002 Jan 22; 2():169-204. PubMed ID: 12806051
    [Abstract] [Full Text] [Related]

  • 7. Design, synthesis and bioactions of novel stable mimetics of lipoxins and aspirin-triggered lipoxins.
    Petasis NA, Akritopoulou-Zanze I, Fokin VV, Bernasconi G, Keledjian R, Yang R, Uddin J, Nagulapalli KC, Serhan CN.
    Prostaglandins Leukot Essent Fatty Acids; 2005 Jan 22; 73(3-4):301-21. PubMed ID: 16098719
    [Abstract] [Full Text] [Related]

  • 8. Novel omega -- 3-derived local mediators in anti-inflammation and resolution.
    Serhan CN.
    Pharmacol Ther; 2005 Jan 22; 105(1):7-21. PubMed ID: 15626453
    [Abstract] [Full Text] [Related]

  • 9. Lipoxins and aspirin-triggered 15-epi-lipoxins are endogenous components of antiinflammation: emergence of the counterregulatory side.
    Serhan CN.
    Arch Immunol Ther Exp (Warsz); 2001 Jan 22; 49(3):177-88. PubMed ID: 11478391
    [Abstract] [Full Text] [Related]

  • 10. A novel rat lipoxin A4 receptor that is conserved in structure and function.
    Chiang N, Takano T, Arita M, Watanabe S, Serhan CN.
    Br J Pharmacol; 2003 May 22; 139(1):89-98. PubMed ID: 12746227
    [Abstract] [Full Text] [Related]

  • 11. Lipoxins: pro-resolution lipid mediators in intestinal inflammation.
    Goh J, Godson C, Brady HR, Macmathuna P.
    Gastroenterology; 2003 Apr 22; 124(4):1043-54. PubMed ID: 12671901
    [Abstract] [Full Text] [Related]

  • 12. Lipoxin A4 inhibits acute edema in mice: implications for the anti-edematogenic mechanism induced by aspirin.
    Menezes-de-Lima O, Kassuya CA, Nascimento AF, Henriques Md, Calixto JB.
    Prostaglandins Other Lipid Mediat; 2006 Sep 22; 80(3-4):123-35. PubMed ID: 16939877
    [Abstract] [Full Text] [Related]

  • 13. Glucocorticoids co-interact with lipoxin A4 via lipoxin A4 receptor (ALX) up-regulation.
    Hashimoto A, Murakami Y, Kitasato H, Hayashi I, Endo H.
    Biomed Pharmacother; 2007 Jan 22; 61(1):81-5. PubMed ID: 17184966
    [Abstract] [Full Text] [Related]

  • 14. Lipoxins and aspirin-triggered lipoxins in resolution of inflammation.
    Romano M, Cianci E, Simiele F, Recchiuti A.
    Eur J Pharmacol; 2015 Aug 05; 760():49-63. PubMed ID: 25895638
    [Abstract] [Full Text] [Related]

  • 15. Liver: the formation and actions of aspirin-triggered lipoxins.
    Clària J, Planagumà A.
    Prostaglandins Leukot Essent Fatty Acids; 2005 Aug 05; 73(3-4):277-82. PubMed ID: 16006110
    [Abstract] [Full Text] [Related]

  • 16. Angiogenesis and lipoxins.
    Fierro IM.
    Prostaglandins Leukot Essent Fatty Acids; 2005 Aug 05; 73(3-4):271-5. PubMed ID: 15982864
    [Abstract] [Full Text] [Related]

  • 17. Lipoxin and synthetic lipoxin analogs: an overview of anti-inflammatory functions and new concepts in immunomodulation.
    Parkinson JF.
    Inflamm Allergy Drug Targets; 2006 Apr 05; 5(2):91-106. PubMed ID: 16613568
    [Abstract] [Full Text] [Related]

  • 18. Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues.
    Takano T, Clish CB, Gronert K, Petasis N, Serhan CN.
    J Clin Invest; 1998 Feb 15; 101(4):819-26. PubMed ID: 9466977
    [Abstract] [Full Text] [Related]

  • 19. [Lipoxins--new view on old mediators carrying potent anti-inflammatory action].
    Jarmakowska K, Kuna P.
    Pol Merkur Lekarski; 2005 May 15; 18(107):491-5. PubMed ID: 16161940
    [Abstract] [Full Text] [Related]

  • 20. Aspirin-triggered lipoxin A4 and lipoxin A4 up-regulate transcriptional corepressor NAB1 in human neutrophils.
    Qiu FH, Devchand PR, Wada K, Serhan CN.
    FASEB J; 2001 Dec 15; 15(14):2736-8. PubMed ID: 11687510
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.